|
Volumn 23, Issue 12, 2005, Pages 2583-2585
|
Standards of proof, standards of practice, and proof of standards: A tale of two trials
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADJUVANT;
HEMOGLOBIN DERIVATIVE;
PLACEBO;
RECOMBINANT ERYTHROPOIETIN;
ERYTHROPOIETIN;
ADJUVANT CHEMOTHERAPY;
ANEMIA;
BLOOD TRANSFUSION;
BONE MARROW SUPPRESSION;
BREAST CANCER;
CANCER RISK;
CLINICAL FEATURE;
CLINICAL PRACTICE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG INDICATION;
EDITORIAL;
HEALTH CARE PERSONNEL;
HUMAN;
MEDICAL EDUCATION;
PATIENT SELECTION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
TREATMENT OUTCOME;
BIOASSAY;
EVIDENCE BASED MEDICINE;
METHODOLOGY;
NOTE;
PRACTICE GUIDELINE;
PUBLISHING;
RANDOMIZED CONTROLLED TRIAL;
REPRODUCIBILITY;
ANEMIA;
ENDPOINT DETERMINATION;
ERYTHROPOIETIN;
EVIDENCE-BASED MEDICINE;
HUMANS;
PRACTICE GUIDELINES;
PUBLISHING;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS;
REPRODUCIBILITY OF RESULTS;
RESEARCH DESIGN;
TREATMENT OUTCOME;
|
EID: 18444407460
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2005.11.910 Document Type: Editorial |
Times cited : (7)
|
References (9)
|